Clinical Trial Update: Audit and Screening Study to Determine the Prevalence of Peripheral Arterial Disease [NA]

View source ↗

Summary

A completed AstraZeneca-sponsored observational study aimed at auditing and screening to determine the prevalence of peripheral arterial disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Snippet

Sponsor: AstraZeneca | Conditions: Peripheral Arterial Disease | NA | Status: COMPLETED